List of Excipients in API irbesartan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing irbesartan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sanofi-Aventis US LLC | AVAPRO | irbesartan | 0024-5850 | CARNAUBA WAX | |
| Sanofi-Aventis US LLC | AVAPRO | irbesartan | 0024-5850 | CELLULOSE, MICROCRYSTALLINE | |
| Sanofi-Aventis US LLC | AVAPRO | irbesartan | 0024-5850 | CROSCARMELLOSE SODIUM | |
| Sanofi-Aventis US LLC | AVAPRO | irbesartan | 0024-5850 | HYPROMELLOSE | |
| Sanofi-Aventis US LLC | AVAPRO | irbesartan | 0024-5850 | LACTOSE MONOHYDRATE | |
| Sanofi-Aventis US LLC | AVAPRO | irbesartan | 0024-5850 | MAGNESIUM STEARATE | |
| Sanofi-Aventis US LLC | AVAPRO | irbesartan | 0024-5850 | POLYETHYLENE GLYCOL 3000 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing irbesartan
Detailed excipient profiles for irbesartan
Excipient focus: CALCIUM STEARATE
irbesartan drug variants containing CALCIUM STEARATE
irbesartan drug variants not containing CALCIUM STEARATE
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
irbesartan drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | irbesartan | 31722-729 |
| Macleods Pharmaceuticals Limited | irbesartan | 33342-047 |
| A-S Medication Solutions | irbesartan | 50090-1284 |
| A-S Medication Solutions | irbesartan | 50090-6938 |
| AvPAK | irbesartan | 50268-440 |
| DIRECTRX | irbesartan | 61919-793 |
| Proficient Rx LP | irbesartan | 63187-737 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
Excipient focus: CARNAUBA WAX
irbesartan drug variants containing CARNAUBA WAX
irbesartan drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
irbesartan drug variants containing CELLULOSE, MICROCRYSTALLINE
irbesartan drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
irbesartan drug variants containing CROSCARMELLOSE SODIUM
irbesartan drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | irbesartan | 31722-729 |
| Macleods Pharmaceuticals Limited | irbesartan | 33342-047 |
| A-S Medication Solutions | irbesartan | 50090-1284 |
| A-S Medication Solutions | irbesartan | 50090-6938 |
| AvPAK | irbesartan | 50268-440 |
| LUPIN LIMITED | irbesartan | 57297-410 |
| DIRECTRX | irbesartan | 61919-793 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
irbesartan drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan | 57297-410 |
| Lupin Pharmaceuticals Inc | irbesartan | 68180-410 |
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing CROSPOVIDONE
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
irbesartan drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | irbesartan | 65862-637 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FERRIC OXIDE RED
irbesartan drug variants containing FERRIC OXIDE RED
irbesartan drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
irbesartan drug variants containing FERRIC OXIDE YELLOW
irbesartan drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
irbesartan drug variants containing FERROSOFERRIC OXIDE
irbesartan drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
irbesartan drug variants containing HYPROMELLOSE
irbesartan drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
irbesartan drug variants containing HYPROMELLOSE 2910
irbesartan drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
irbesartan drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Lake Erie Medical DBA Quality Care Products LLC | irbesartan | 35356-854 |
| Solco healthcare US LLC | irbesartan | 43547-277 |
| Amneal Pharmaceuticals LLC | irbesartan | 65162-284 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
irbesartan drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | irbesartan | 54868-4199 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
irbesartan drug variants containing LACTOSE MONOHYDRATE
irbesartan drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
irbesartan drug variants containing LECITHIN, SOYBEAN
irbesartan drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
irbesartan drug variants containing MAGNESIUM STEARATE
irbesartan drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
irbesartan drug variants containing MANNITOL
irbesartan drug variants not containing MANNITOL
Excipient focus: POLOXAMER 188
irbesartan drug variants containing POLOXAMER 188
irbesartan drug variants not containing POLOXAMER 188
Excipient focus: POLYETHYLENE GLYCOL
irbesartan drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | irbesartan and hydrochlorothiazide | 0024-5855 |
| Winthrop US a business of sanofi-aventis US LLC | irbesartan and hydrochlorothiazide | 0955-1045 |
| Bryant Ranch Prepack | irbesartan and hydrochlorothiazide | 71335-1392 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 300
irbesartan drug variants containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Hisun Pharmaceuticals USA Inc | irbesartan | 42658-121 |
| A-S Medication Solutions | irbesartan | 50090-4519 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing POLYETHYLENE GLYCOL 300
Excipient focus: POLYETHYLENE GLYCOL 3000
irbesartan drug variants containing POLYETHYLENE GLYCOL 3000
irbesartan drug variants not containing POLYETHYLENE GLYCOL 3000
Excipient focus: POLYETHYLENE GLYCOL 3350
irbesartan drug variants containing POLYETHYLENE GLYCOL 3350
irbesartan drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
irbesartan drug variants containing POLYETHYLENE GLYCOL 400
irbesartan drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
irbesartan drug variants containing POLYETHYLENE GLYCOL 6000
irbesartan drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYSORBATE 80
irbesartan drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | irbesartan | 65862-637 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
irbesartan drug variants containing POLYVINYL ALCOHOL
irbesartan drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
irbesartan drug variants containing POVIDONE
irbesartan drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
irbesartan drug variants containing POVIDONE K25
irbesartan drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K29/32
irbesartan drug variants containing POVIDONE K29/32
irbesartan drug variants not containing POVIDONE K29/32
Excipient focus: POVIDONE K30
irbesartan drug variants containing POVIDONE K30
irbesartan drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
irbesartan drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
irbesartan drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
irbesartan drug variants containing SILICON DIOXIDE
irbesartan drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
irbesartan drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan | 57297-410 |
| Lupin Pharmaceuticals Inc | irbesartan | 68180-410 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
irbesartan drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | irbesartan | 33342-047 |
| DIRECTRX | irbesartan | 61919-793 |
| Proficient Rx LP | irbesartan | 63187-737 |
| Bryant Ranch Prepack | irbesartan | 63629-5241 |
| Bryant Ranch Prepack | irbesartan | 63629-8259 |
| Aurobindo Pharma Limited | irbesartan | 65862-637 |
| REMEDYREPACK INC | irbesartan | 70518-1328 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
irbesartan drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | irbesartan | 65862-637 |
| Aurobindo Pharma Limited | irbesartan and hydrochlorothiazide | 65862-629 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
irbesartan drug variants containing STARCH, CORN
irbesartan drug variants not containing STARCH, CORN
Excipient focus: TALC
irbesartan drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | irbesartan | 33342-047 |
| DIRECTRX | irbesartan | 61919-793 |
| Proficient Rx LP | irbesartan | 63187-737 |
| Bryant Ranch Prepack | irbesartan | 63629-5241 |
| Bryant Ranch Prepack | irbesartan | 63629-8259 |
| Aurobindo Pharma Limited | irbesartan | 65862-637 |
| REMEDYREPACK INC | irbesartan | 70518-1328 |
| >Company | >Ingredient | >NDC |
irbesartan drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
irbesartan drug variants containing TITANIUM DIOXIDE
irbesartan drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
